Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02086110 · ClinicalTrials.gov registry record · NA
Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02086110 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 11 participants.
The verdict
NCT02086110, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the tolerability of dietary supplements and if these supplements can promote a healthy bacterial environment in the intestines of children with autism spectrum disorders and gastrointestinal complaints.
Interventions
- DIETARY_SUPPLEMENT Prebiotic
- DIETARY_SUPPLEMENT Synbiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-06-06 |
| Est. Completion | 2015-11-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02086110
The ClinicalTrials.gov registry entry for NCT02086110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prebiotic is the first listed.
NCT02086110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02086110 about?
NCT02086110 is a clinical study titled "Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism". The purpose of this study is to determine the tolerability of dietary supplements and if these supplements can promote a healthy bacterial environment in the intestines of children with autism spectrum disorders and gastrointestinal complaints.
What is the current status of trial NCT02086110?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-06-06. Estimated completion is 2015-11-16.
What interventions are being tested in trial NCT02086110?
The interventions under investigation include: Prebiotic (DIETARY_SUPPLEMENT), Synbiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02086110?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.